Screener
Immuneering Corporation IMRX Q3 2025 earnings
Reported November 12, 2025 · After market close
EPS-$0.38Miss by $0.01
EPS estimate-$0.37
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$0.29
Versus estimates
Diluted EPS
FAQ
- When did Immuneering Corporation report Q3 2025 earnings?
- Immuneering Corporation (IMRX) reported Q3 2025 earnings on November 12, 2025 after market close.
- What were Immuneering Corporation's Q3 2025 revenue and EPS?
- Immuneering Corporation reported eps of $-0.38 for Q3 2025.
- Did Immuneering Corporation beat estimates in Q3 2025?
- EPS missed the consensus estimate of $-0.37 by $0.01.
- How did Immuneering Corporation's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 22.4% from $-0.49.
- Where can I find Immuneering Corporation's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001790340-25-000133) and the 10-Q periodic report (0001790340-25-000135) directly on SEC EDGAR. The filing index links above go to sec.gov.
